Global Hereditary Angioedema Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

July 2022 | 93 pages | ID: G48A18D7A75EN
GlobalInfoResearch

Abstracts

The Hereditary Angioedema market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hereditary Angioedema market size is estimated to be worth US$ 1704.7 million in 2021 and is forecast to a readjusted size of USD 2731.4 million by 2028 with a CAGR of 7.0% during review period. Retail Pharmacies accounting for % of the Hereditary Angioedema global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While C1 Esterase Inhibitor segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Hereditary Angioedema include Pharming Group NV, Takeda, CSL Limited, iBio Inc., and BioCryst Pharmaceuticals, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Hereditary Angioedema market is split by Type and by Distribution Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• C1 Esterase Inhibitor
• Kallikrein Inhibitor
• Selective Bradykinin B2 Receptor Antagonist

Market segment by Distribution Channel can be divided into

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

The key market players for global Hereditary Angioedema market are listed below:

• Pharming Group NV
• Takeda
• CSL Limited
• iBio Inc.
• BioCryst Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.

Market segment by region, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
• South America (Brazil, Argentina, Colombia, and Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Hereditary Angioedema product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Hereditary Angioedema, with price, sales, revenue and global market share of Hereditary Angioedema from 2019 to 2022.

Chapter 3, the Hereditary Angioedema competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Hereditary Angioedema breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, distribution channel, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hereditary Angioedema market forecast, by regions, type and distribution channel, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Angioedema.

Chapter 13, 14, and 15, to describe Hereditary Angioedema sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Hereditary Angioedema Introduction
1.2 Market Analysis by Type
  1.2.1 Overview: Global Hereditary Angioedema Revenue by Type: 2017 Versus 2021 Versus 2028
  1.2.2 C1 Esterase Inhibitor
  1.2.3 Kallikrein Inhibitor
  1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Market Analysis by Distribution Channel
  1.3.1 Overview: Global Hereditary Angioedema Revenue by Distribution Channel: 2017 Versus 2021 Versus 2028
  1.3.2 Retail Pharmacies
  1.3.3 Hospital Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Hereditary Angioedema Market Size & Forecast
  1.4.1 Global Hereditary Angioedema Sales in Value (2017 & 2021 & 2028)
  1.4.2 Global Hereditary Angioedema Sales in Volume (2017-2028)
  1.4.3 Global Hereditary Angioedema Price (2017-2028)
1.5 Global Hereditary Angioedema Production Capacity Analysis
  1.5.1 Global Hereditary Angioedema Total Production Capacity (2017-2028)
  1.5.2 Global Hereditary Angioedema Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
  1.6.1 Hereditary Angioedema Market Drivers
  1.6.2 Hereditary Angioedema Market Restraints
  1.6.3 Hereditary Angioedema Trends Analysis

2 MANUFACTURERS PROFILES

2.1 Pharming Group NV
  2.1.1 Pharming Group NV Details
  2.1.2 Pharming Group NV Major Business
  2.1.3 Pharming Group NV Hereditary Angioedema Product and Services
  2.1.4 Pharming Group NV Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Takeda
  2.2.1 Takeda Details
  2.2.2 Takeda Major Business
  2.2.3 Takeda Hereditary Angioedema Product and Services
  2.2.4 Takeda Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL Limited
  2.3.1 CSL Limited Details
  2.3.2 CSL Limited Major Business
  2.3.3 CSL Limited Hereditary Angioedema Product and Services
  2.3.4 CSL Limited Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 iBio Inc.
  2.4.1 iBio Inc. Details
  2.4.2 iBio Inc. Major Business
  2.4.3 iBio Inc. Hereditary Angioedema Product and Services
  2.4.4 iBio Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BioCryst Pharmaceuticals, Inc.
  2.5.1 BioCryst Pharmaceuticals, Inc. Details
  2.5.2 BioCryst Pharmaceuticals, Inc. Major Business
  2.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product and Services
  2.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Ionis Pharmaceuticals, Inc.
  2.6.1 Ionis Pharmaceuticals, Inc. Details
  2.6.2 Ionis Pharmaceuticals, Inc. Major Business
  2.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product and Services
  2.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 HEREDITARY ANGIOEDEMA BREAKDOWN DATA BY MANUFACTURER

3.1 Global Hereditary Angioedema Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hereditary Angioedema Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hereditary Angioedema
3.4 Market Concentration Rate
  3.4.1 Top 3 Hereditary Angioedema Manufacturer Market Share in 2021
  3.4.2 Top 6 Hereditary Angioedema Manufacturer Market Share in 2021
3.5 Global Hereditary Angioedema Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hereditary Angioedema Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 MARKET ANALYSIS BY REGION

4.1 Global Hereditary Angioedema Market Size by Region
  4.1.1 Global Hereditary Angioedema Sales in Volume by Region (2017-2028)
  4.1.2 Global Hereditary Angioedema Revenue by Region (2017-2028)
4.2 North America Hereditary Angioedema Revenue (2017-2028)
4.3 Europe Hereditary Angioedema Revenue (2017-2028)
4.4 Asia-Pacific Hereditary Angioedema Revenue (2017-2028)
4.5 South America Hereditary Angioedema Revenue (2017-2028)
4.6 Middle East and Africa Hereditary Angioedema Revenue (2017-2028)

5 MARKET SEGMENT BY TYPE

5.1 Global Hereditary Angioedema Sales in Volume by Type (2017-2028)
5.2 Global Hereditary Angioedema Revenue by Type (2017-2028)
5.3 Global Hereditary Angioedema Price by Type (2017-2028)

6 MARKET SEGMENT BY DISTRIBUTION CHANNEL

6.1 Global Hereditary Angioedema Sales in Volume by Distribution Channel (2017-2028)
6.2 Global Hereditary Angioedema Revenue by Distribution Channel (2017-2028)
6.3 Global Hereditary Angioedema Price by Distribution Channel (2017-2028)

7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL

7.1 North America Hereditary Angioedema Sales by Type (2017-2028)
7.2 North America Hereditary Angioedema Sales by Distribution Channel (2017-2028)
7.3 North America Hereditary Angioedema Market Size by Country
  7.3.1 North America Hereditary Angioedema Sales in Volume by Country (2017-2028)
  7.3.2 North America Hereditary Angioedema Revenue by Country (2017-2028)
  7.3.3 United States Market Size and Forecast (2017-2028)
  7.3.4 Canada Market Size and Forecast (2017-2028)
  7.3.5 Mexico Market Size and Forecast (2017-2028)

8 EUROPE BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL

8.1 Europe Hereditary Angioedema Sales by Type (2017-2028)
8.2 Europe Hereditary Angioedema Sales by Distribution Channel (2017-2028)
8.3 Europe Hereditary Angioedema Market Size by Country
  8.3.1 Europe Hereditary Angioedema Sales in Volume by Country (2017-2028)
  8.3.2 Europe Hereditary Angioedema Revenue by Country (2017-2028)
  8.3.3 Germany Market Size and Forecast (2017-2028)
  8.3.4 France Market Size and Forecast (2017-2028)
  8.3.5 United Kingdom Market Size and Forecast (2017-2028)
  8.3.6 Russia Market Size and Forecast (2017-2028)
  8.3.7 Italy Market Size and Forecast (2017-2028)

9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL

9.1 Asia-Pacific Hereditary Angioedema Sales by Type (2017-2028)
9.2 Asia-Pacific Hereditary Angioedema Sales by Distribution Channel (2017-2028)
9.3 Asia-Pacific Hereditary Angioedema Market Size by Region
  9.3.1 Asia-Pacific Hereditary Angioedema Sales in Volume by Region (2017-2028)
  9.3.2 Asia-Pacific Hereditary Angioedema Revenue by Region (2017-2028)
  9.3.3 China Market Size and Forecast (2017-2028)
  9.3.4 Japan Market Size and Forecast (2017-2028)
  9.3.5 Korea Market Size and Forecast (2017-2028)
  9.3.6 India Market Size and Forecast (2017-2028)
  9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
  9.3.8 Australia Market Size and Forecast (2017-2028)

10 SOUTH AMERICA BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL

10.1 South America Hereditary Angioedema Sales by Type (2017-2028)
10.2 South America Hereditary Angioedema Sales by Distribution Channel (2017-2028)
10.3 South America Hereditary Angioedema Market Size by Country
  10.3.1 South America Hereditary Angioedema Sales in Volume by Country (2017-2028)
  10.3.2 South America Hereditary Angioedema Revenue by Country (2017-2028)
  10.3.3 Brazil Market Size and Forecast (2017-2028)
  10.3.4 Argentina Market Size and Forecast (2017-2028)

11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL

11.1 Middle East & Africa Hereditary Angioedema Sales by Type (2017-2028)
11.2 Middle East & Africa Hereditary Angioedema Sales by Distribution Channel (2017-2028)
11.3 Middle East & Africa Hereditary Angioedema Market Size by Country
  11.3.1 Middle East & Africa Hereditary Angioedema Sales in Volume by Country (2017-2028)
  11.3.2 Middle East & Africa Hereditary Angioedema Revenue by Country (2017-2028)
  11.3.3 Turkey Market Size and Forecast (2017-2028)
  11.3.4 Egypt Market Size and Forecast (2017-2028)
  11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
  11.3.6 South Africa Market Size and Forecast (2017-2028)

12 RAW MATERIAL AND INDUSTRY CHAIN

12.1 Raw Material of Hereditary Angioedema and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hereditary Angioedema
12.3 Hereditary Angioedema Production Process
12.4 Hereditary Angioedema Industrial Chain

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
13.2 Hereditary Angioedema Typical Distributors
13.3 Hereditary Angioedema Typical Customers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Hereditary Angioedema Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Hereditary Angioedema Revenue by Distribution Channel, (USD Million), 2017 & 2021 & 2028
Table 3. Pharming Group NV Basic Information, Manufacturing Base and Competitors
Table 4. Pharming Group NV Major Business
Table 5. Pharming Group NV Hereditary Angioedema Product and Services
Table 6. Pharming Group NV Hereditary Angioedema Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Takeda Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Major Business
Table 9. Takeda Hereditary Angioedema Product and Services
Table 10. Takeda Hereditary Angioedema Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 12. CSL Limited Major Business
Table 13. CSL Limited Hereditary Angioedema Product and Services
Table 14. CSL Limited Hereditary Angioedema Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. iBio Inc. Basic Information, Manufacturing Base and Competitors
Table 16. iBio Inc. Major Business
Table 17. iBio Inc. Hereditary Angioedema Product and Services
Table 18. iBio Inc. Hereditary Angioedema Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. BioCryst Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. BioCryst Pharmaceuticals, Inc. Major Business
Table 21. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product and Services
Table 22. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Ionis Pharmaceuticals, Inc. Major Business
Table 25. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product and Services
Table 26. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Hereditary Angioedema Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 28. Global Hereditary Angioedema Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Hereditary Angioedema, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Hereditary Angioedema Production Capacity by Company, (MT): 2020 VS 2021
Table 31. Head Office and Hereditary Angioedema Production Site of Key Manufacturer
Table 32. Hereditary Angioedema New Entrant and Capacity Expansion Plans
Table 33. Hereditary Angioedema Mergers & Acquisitions in the Past Five Years
Table 34. Global Hereditary Angioedema Sales by Region (2017-2022) & (MT)
Table 35. Global Hereditary Angioedema Sales by Region (2023-2028) & (MT)
Table 36. Global Hereditary Angioedema Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Hereditary Angioedema Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Hereditary Angioedema Sales by Type (2017-2022) & (MT)
Table 39. Global Hereditary Angioedema Sales by Type (2023-2028) & (MT)
Table 40. Global Hereditary Angioedema Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Hereditary Angioedema Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Hereditary Angioedema Price by Type (2017-2022) & (USD/Kg)
Table 43. Global Hereditary Angioedema Price by Type (2023-2028) & (USD/Kg)
Table 44. Global Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
Table 45. Global Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
Table 46. Global Hereditary Angioedema Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 47. Global Hereditary Angioedema Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 48. Global Hereditary Angioedema Price by Distribution Channel (2017-2022) & (USD/Kg)
Table 49. Global Hereditary Angioedema Price by Distribution Channel (2023-2028) & (USD/Kg)
Table 50. North America Hereditary Angioedema Sales by Country (2017-2022) & (MT)
Table 51. North America Hereditary Angioedema Sales by Country (2023-2028) & (MT)
Table 52. North America Hereditary Angioedema Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Hereditary Angioedema Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Hereditary Angioedema Sales by Type (2017-2022) & (MT)
Table 55. North America Hereditary Angioedema Sales by Type (2023-2028) & (MT)
Table 56. North America Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
Table 57. North America Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
Table 58. Europe Hereditary Angioedema Sales by Country (2017-2022) & (MT)
Table 59. Europe Hereditary Angioedema Sales by Country (2023-2028) & (MT)
Table 60. Europe Hereditary Angioedema Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Hereditary Angioedema Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Hereditary Angioedema Sales by Type (2017-2022) & (MT)
Table 63. Europe Hereditary Angioedema Sales by Type (2023-2028) & (MT)
Table 64. Europe Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
Table 65. Europe Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
Table 66. Asia-Pacific Hereditary Angioedema Sales by Region (2017-2022) & (MT)
Table 67. Asia-Pacific Hereditary Angioedema Sales by Region (2023-2028) & (MT)
Table 68. Asia-Pacific Hereditary Angioedema Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Hereditary Angioedema Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Hereditary Angioedema Sales by Type (2017-2022) & (MT)
Table 71. Asia-Pacific Hereditary Angioedema Sales by Type (2023-2028) & (MT)
Table 72. Asia-Pacific Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
Table 73. Asia-Pacific Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
Table 74. South America Hereditary Angioedema Sales by Country (2017-2022) & (MT)
Table 75. South America Hereditary Angioedema Sales by Country (2023-2028) & (MT)
Table 76. South America Hereditary Angioedema Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Hereditary Angioedema Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Hereditary Angioedema Sales by Type (2017-2022) & (MT)
Table 79. South America Hereditary Angioedema Sales by Type (2023-2028) & (MT)
Table 80. South America Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
Table 81. South America Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
Table 82. Middle East & Africa Hereditary Angioedema Sales by Region (2017-2022) & (MT)
Table 83. Middle East & Africa Hereditary Angioedema Sales by Region (2023-2028) & (MT)
Table 84. Middle East & Africa Hereditary Angioedema Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Hereditary Angioedema Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Hereditary Angioedema Sales by Type (2017-2022) & (MT)
Table 87. Middle East & Africa Hereditary Angioedema Sales by Type (2023-2028) & (MT)
Table 88. Middle East & Africa Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
Table 89. Middle East & Africa Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
Table 90. Hereditary Angioedema Raw Material
Table 91. Key Manufacturers of Hereditary Angioedema Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Hereditary Angioedema Typical Distributors
Table 95. Hereditary Angioedema Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Hereditary Angioedema Picture
Figure 2. Global Hereditary Angioedema Revenue Market Share by Type in 2021
Figure 3. C1 Esterase Inhibitor
Figure 4. Kallikrein Inhibitor
Figure 5. Selective Bradykinin B2 Receptor Antagonist
Figure 6. Global Hereditary Angioedema Revenue Market Share by Distribution Channel in 2021
Figure 7. Retail Pharmacies
Figure 8. Hospital Pharmacies
Figure 9. Online Pharmacies
Figure 10. Global Hereditary Angioedema Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 11. Global Hereditary Angioedema Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Hereditary Angioedema Sales (2017-2028) & (MT)
Figure 13. Global Hereditary Angioedema Price (2017-2028) & (USD/Kg)
Figure 14. Global Hereditary Angioedema Production Capacity (2017-2028) & (MT)
Figure 15. Global Hereditary Angioedema Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Hereditary Angioedema Market Drivers
Figure 17. Hereditary Angioedema Market Restraints
Figure 18. Hereditary Angioedema Market Trends
Figure 19. Global Hereditary Angioedema Sales Market Share by Manufacturer in 2021
Figure 20. Global Hereditary Angioedema Revenue Market Share by Manufacturer in 2021
Figure 21. Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Hereditary Angioedema Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Hereditary Angioedema Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Hereditary Angioedema Sales Market Share by Region (2017-2028)
Figure 25. Global Hereditary Angioedema Revenue Market Share by Region (2017-2028)
Figure 26. North America Hereditary Angioedema Revenue (2017-2028) & (USD Million)
Figure 27. Europe Hereditary Angioedema Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Hereditary Angioedema Revenue (2017-2028) & (USD Million)
Figure 29. South America Hereditary Angioedema Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Hereditary Angioedema Revenue (2017-2028) & (USD Million)
Figure 31. Global Hereditary Angioedema Sales Market Share by Type (2017-2028)
Figure 32. Global Hereditary Angioedema Revenue Market Share by Type (2017-2028)
Figure 33. Global Hereditary Angioedema Price by Type (2017-2028) & (USD/Kg)
Figure 34. Global Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
Figure 35. Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2017-2028)
Figure 36. Global Hereditary Angioedema Price by Distribution Channel (2017-2028) & (USD/Kg)
Figure 37. North America Hereditary Angioedema Sales Market Share by Type (2017-2028)
Figure 38. North America Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
Figure 39. North America Hereditary Angioedema Sales Market Share by Country (2017-2028)
Figure 40. North America Hereditary Angioedema Revenue Market Share by Country (2017-2028)
Figure 41. United States Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Hereditary Angioedema Sales Market Share by Type (2017-2028)
Figure 45. Europe Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
Figure 46. Europe Hereditary Angioedema Sales Market Share by Country (2017-2028)
Figure 47. Europe Hereditary Angioedema Revenue Market Share by Country (2017-2028)
Figure 48. Germany Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Hereditary Angioedema Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
Figure 55. Asia-Pacific Hereditary Angioedema Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Hereditary Angioedema Revenue Market Share by Region (2017-2028)
Figure 57. China Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Hereditary Angioedema Sales Market Share by Type (2017-2028)
Figure 64. South America Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
Figure 65. South America Hereditary Angioedema Sales Market Share by Country (2017-2028)
Figure 66. South America Hereditary Angioedema Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Hereditary Angioedema Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
Figure 71. Middle East & Africa Hereditary Angioedema Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Hereditary Angioedema Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Hereditary Angioedema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Hereditary Angioedema in 2021
Figure 78. Manufacturing Process Analysis of Hereditary Angioedema
Figure 79. Hereditary Angioedema Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source